Thermo Fisher says its COVID-19 tests accurately detect Omicron variant | Inquirer News

Thermo Fisher says its COVID-19 tests accurately detect Omicron variant

/ 02:48 PM November 29, 2021

FILE PHOTO: A social distancing sign is seen amid the spread of the coronavirus disease (COVID-19), in Leicester, Britain, May 27, 2021. REUTERS/Andrew Boyers

A social distancing sign is seen amid the spread of the coronavirus disease (COVID-19), in Leicester, Britain, May 27, 2021. REUTERS FILE PHOTO

Thermo Fisher Scientific Inc said on Monday its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron that has made several countries to shut their borders.

The World Health Organization (WHO) last week classified the Omicron variant as a SARS-CoV-2 “variant of concern,” saying it may spread more quickly than other forms.

Article continues after this advertisement

Thermo Fisher’s TaqPath COVID-19 assays can report accurate results even in the case where one of the gene targets is impacted by a mutation, the company said in a statement. “This assay can be used not only to successfully detect COVID-19 but… it also be used as a proxy for the variant,” Mark Stevenson, chief operating officer at Thermo Fisher Scientific, said in an interview.

FEATURED STORIES

Stevenson said this is the only COVID-19 diagnostic test authorized by the U.S. Food and Drug Administration and currently in use by health systems that can be used to indicate if a case is caused by the Omicron variant.

Test samples must still be sent to a lab for sequencing to confirm that the case was caused by Omicron and not another variant with similar features, such as the Alpha variant, he said.

Omicron, which was first detected in Southern Africa, has now been confirmed in Australia, Belgium, Botswana, Britain, Denmark, Germany, Hong Kong, Israel, Italy, the Netherlands, France, South Africa, and the United States’ neighbor to the north, Canada.

The WHO said it was working with technical experts to understand the potential impact of the variant on existing countermeasures against COVID-19, including vaccines.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2025 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.